Year of discovery, growth at UCI

High points of 2009 range from the volleyball court to the operating room with demonstrations of drive and dedication by UC Irvine students, faculty and staff.

Dr. Homayoon Sanati

Treating cancer in older adults

Geriatric oncologist Dr. Homayoon Sanati decries the underrepresentation of seniors in clinical trials. He’s working with his UCI colleagues to provide a solution.

Alzheimer's lesions found in mice retinas

The eyes may be the windows to the soul, but new research indicates they also may mirror a brain ravaged…

UCI neuroscientist Zhiqun Tan

Alzheimer’s lesions found in the retina

UC Irvine neuroscientists have found that retinas in mice genetically altered to have Alzheimer’s undergo changes similar to those that occur in the brain – most notably the accumulation of amyloid plaque lesions.

Alzheimer's retina

UC Irvine neuroscientists have found that retinas in mice genetically altered to have Alzheimer’s undergo changes similar to those that occur in the brain – most notably the accumulation of amyloid plaque lesions.

Frank M. LaFerla

UCImpact: Alzheimer’s disease

UC Irvine’s impact on Alzheimer’s research is acknowledged on World Alzheimer’s Day.

Linda Scheck

Alzheimer’s art creates lasting memories

Nine paintings created through an Alzheimer’s Association program called Memories in the Making are on display at UCI MIND.

Memory art

Nine paintings created through an Alzheimer’s Association program called Memories in the Making are on display at UCI MIND.

Alzheimer's gene

A UC Irvine study has found that a gene called TOMM40 appears twice as often in people with Alzheimer’s disease than in those without it. Alzheimer’s, for which there is no cure, is the leading cause of elderly dementia.

Frank LaFerla and Mathew Blurton-Jones

Neural stem cells offer potential treatment for Alzheimer’s disease

UC Irvine scientists have shown for the first time that neural stem cells can rescue memory in mice with advanced Alzheimer’s disease, raising hopes of a potential treatment for the leading cause of elderly dementia that afflicts 5.3 million people in the U.S.